webinar register page

Webinar banner
ASBMR Webinar Series: Dilemmas in Clinical Practice: Early-Onset Osteoporosis
This presentation will review specific diagnostic and management considerations that apply to premenopausal women with early-onset osteoporosis. Evaluation of premenopausal women with evidence of bone fragility focuses on a search for both primary and secondary causes, since identification of underlying conditions can often help to guide management decisions. Few clinical trials have assessed treatment effects in premenopausal women, and data on fracture prevention are very limited. Available data regarding treatment approaches for both idiopathic osteoporosis and pregnancy and lactation associated osteoporosis will be discussed.

As a result of this webinar, attendees will be able to:

• Consider diagnostic issues specific to early-onset
osteoporosis

• Evaluated patients presenting with early-onset
osteoporosis and pregnancy/lactation associated
osteoporosis

• Consider data guiding potential management options
for premenopausal osteoporosis and
pregnancy/lactation associated osteoporosis

Nov 16, 2021 01:00 PM in Eastern Time (US and Canada)

* Required information
Loading

Speakers

Adi Cohen, M.D., M.S.
@Columbia University Medical Center
Dr. Adi Cohen holds the position of Associate Professor of Medicine at Columbia University Irving Medical Center in the Division of Endocrinology at Columbia University Irving Medical Center. Dr. Cohen is the Director of the Early-Onset Osteoporosis Center within the Metabolic Bone Diseases Program at CUIMC. Dr. Cohen has published multiple articles on osteoporosis and bone health in premenopausal women. Her current research focuses on the use of imaging tools for the noninvasive assessment of bone microstructure, bone biopsy techniques for the study of bone structure and bone metabolism, and genetic studies to better understand disease mechanisms and etiologies. Current studies investigate the pathogenesis of both idiopathic osteoporosis in premenopausal women (IOP) and pregnancy and lactation associated osteoporosis (PLO), as well as various treatment options for women with these conditions.